Home

Clinical Trials / Essais cliniques

Canada is widely known for its extensive clinical research about skin disease. There are often clinical trials underway in your area and you may benefit from the experimental medication or treatments they include. Click the links below to learn more about clinical trials happening across Canada. Select the skin disease you're interested in from the left menu and the province or territory from the right menu to learn about clinical trials being conducted in your area. Click "Submit". Then, click on the name of the clinical trial to read about it:
Skin DiseaseProvince / Territory
Trialsort iconSkin DiseaseProvince & Territory
A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 MelanomaSkin CancersAlberta
A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 MelanomaSkin CancersNova Scotia
Phase II, 2nd Line Melanoma - RAND MonotherapySkin CancersAlberta
Phase II, 2nd Line Melanoma - RAND MonotherapySkin CancersQuebec
Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III MelanomaSkin Cancers
Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in MelanomaSkin CancersAlberta
Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in MelanomaSkin CancersNova Scotia
Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in MelanomaSkin CancersOntario
Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in MelanomaSkin CancersQuebec
Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant MelanomaSkin CancersAlberta
Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant MelanomaSkin CancersBritish Columbia
Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant MelanomaSkin CancersManitoba
Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant MelanomaSkin CancersOntario
Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant MelanomaSkin CancersQuebec
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid TumorsSkin CancersOntario
« first‹ previous123456789next ›last »

Contact Information:

Canadian Skin Patient Alliance
2446 Bank Street, Suite 383
Ottawa, Ontario
K1V 1A8
 

Sheri Pilon, Program & Services Manager
phone: 613-224-4266
fax: 613-422- 4267
 

pageTracker._trackPageview();